End-Stage Renal Disease Program Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the End-Stage Renal Disease Program

  • 617-355-7636
  • International: +1-617-355-5209

At Boston Children’s Hospital, our researchers are committed to developing new treatments for patients with end-stage renal disease, including more effective medications and new approaches to treating polycystic kidney disease.

Scientists in our Kidney Transplant Program are working to improve medications used after transplant, with the goal of improving transplant outcomes and reducing unwanted side effects and complications.

Additional information about our research is available on our research Web site, including a list of transplant studies currently enrolling eligible patients.

Transplantation Research Center (TRC)

Our Transplantation Research Center (TRC), affiliated with nearby Brigham and Women’s Hospital, provides an environment for scientists and physicians from both institutions to collaborate in matters related to transplantation and immunology.

The TRC is intended to share new knowledge, and to speed results gained from research into innovative and improved approaches to caring for kids who need transplant.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close